Adage Capital Partners Gp, L.L.C. Icosavax, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$5.7 - $10.33 $485,241 - $879,392	-85,130 Reduced 21.01%	320,000 $1.83 Million
Q1 2022 May 16, 2022	BUY	$4.41 - $22.5 $1.79 Million - $9.12 Million	405,130 New	405,130 $2.85 Million

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.